Zhe Sun

发表

Impact of antithrombotic drugs on the accuracy of fecal occult blood testing for advanced colorectal neoplasia screening: a meta-analysis and systematic review

Zhipeng Lin, Zheng Yuan, Yu Zhang, 2021, Zeitschrift für Gastroenterologie.

Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia

Ligen Liu, Lei Gao, Sanbin Wang, 2022, Blood Cancer Journal.

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

Jiaping He, W. Cao, Wen-Juan Yin, 2022, Blood Cancer Journal.

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

M. Petri, T. Dörner, A. Koch, 2022, Annals of the Rheumatic Diseases.

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

M. Zhang, Yongliang Zhang, Jiaping He, 2019, Blood.

Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis

M. Alphonse, S. Kwatra, Karen Cravero, 2022, bioRxiv.

Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio

Yingchen Yang, N. Yang, Xijun Zhao, 2022, Journal of Gastrointestinal Surgery.

CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside

P. Kong, Yongliang Zhang, Ligen Liu, 2019, Blood.

Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance

Leida Zhang, L. Bai, Sijin Li, 2023, Frontiers in immunology.

Lebrikizumab Decreases Inflammatory Biomarkers in Patients with Asthma: Data from Randomized Phase 3 Trials (LAVOLTA I and II)

J. Silverberg, S. Szefler, A. Blauvelt, 2023, Journal of Allergy and Clinical Immunology.